Plain-English translation of NCT06072690 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing how dual bronchodilation—a combination breathing medication—affects both your lungs and your heart in people who have recently been diagnosed with moderate-to-severe COPD. Researchers know that COPD can affect the heart as well as the lungs, but they want to understand whether this medication can help both systems. You'll be compared to a similar group of people without COPD to see how the treatment works.
People with COPD often have heart problems too, but these cardiovascular issues are sometimes overlooked in treatment. Early studies suggest this medication might help not just breathing, but also heart function—but researchers need to study newly diagnosed patients to understand the true initial effects of the treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the research center for a comprehensive health assessment before starting the medication, which will include breathing tests, heart tests, and questions about your quality of life. You'll then take the dual bronchodilation medication daily for 12 weeks. After 12 weeks, you'll return for another complete evaluation to see how the treatment has affected your lungs, heart, and overall well-being.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Lithuania